{"id":"W4312654940","doi":"10.1136/ijgc-2022-esgo.546","title":"2022-RA-687-ESGO ARTISTRY-7: phase 3, multicenter study of nemvaleukin alfa plus pembrolizumab versus chemotherapy in patients with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer (GOG-3063; ENGOT-OV68)","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Pembrolizumab; Medicine; Ovarian cancer; Internal medicine; Oncology; Chemotherapy; Tolerability; Fallopian tube; Carboplatin; Cancer; Bevacizumab; Gastroenterology; Immunotherapy; Cisplatin; Gynecology; Adverse effect","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001559211,0.001561291,0.001636014,0.0004610133,0.0004054346,0.001141349,0.001138508,0.001565878,0.005206112],"category_scores_gemma":[0.0007673911,0.0005499699,0.00159912,0.0003427761,0.0009633495,0.0008303421,0.0003787572,0.0041445,0.001645533],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008350484,"about_ca_system_score_gemma":0.001701894,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00164217,"about_ca_topic_score_gemma":0.004969103,"domain_scores_codex":[0.9996332,0.0001901487,0.00001073216,0.00004668344,0.0000284658,0.00009080365],"domain_scores_gemma":[0.9994986,0.00006851635,0.00006973093,0.00003320637,0.00003181,0.0002981038],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7826729,0.05902749,0.005050868,0.001080509,0.002639562,0.0002155299,0.0003364705,0.002890087,0.02766494,0.0007773467,0.0108971,0.1067471],"study_design_scores_gemma":[0.773083,0.2138109,0.006156997,0.00004631299,0.0005778249,0.0001576548,0.0000824829,0.001108207,0.001406822,0.0002489013,0.003292016,0.00002889984],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.98502,0.003270251,0.0007166729,0.001099536,0.0003493238,0.002782531,0.002224461,0.0002563272,0.004280902],"genre_scores_gemma":[0.9760059,0.002895061,0.002414597,0.00231289,0.0003205425,0.003422963,0.004999664,0.00009004274,0.007538353],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005206112,"threshold_uncertainty_score":0.01741618,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02393015304150537,"score_gpt":0.3294848996747471,"score_spread":0.3055547466332418,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}